Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_assertion type Assertion NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_head.
- NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_assertion description "[PTGF-beta overexpression from a recombinant adenoviral vector (AdPTGF-beta) led to an 80% reduction in MDA-MB-468 breast cancer cell viability and a 50-60% reduction in other human breast cancer cell lines studied, including MCF-7 cells, which are resistant to growth inhibition by recombinant wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_provenance.
- NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_assertion evidence source_evidence_literature NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_provenance.
- NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_assertion SIO_000772 10777512 NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_provenance.
- NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_assertion wasDerivedFrom befree-20150227 NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_provenance.
- NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_assertion wasGeneratedBy ECO_0000203 NP825138.RAbDJSHkjTpSaXrpLRlzTWAD7LA6ypb-xo-hNKYgbS8e4130_provenance.